NextGen Omics US 2023
三月 30 - 31, 2023
Boston, Massachusetts
United States
Share this event
Description
On March 30 and 31, omics experts from around the world will meet in Boston at NextGen Omics US 2023 to discuss the future of next-generation sequencing, multiomic single-cell and spatial analyses, and genome editing in drug discovery and therapeutic development.
We will be there (on the stage and in Booth 5) and are looking forward to seeing you there, too.
What’s Happening in Booth 5
Your next life-changing discoveries are on the horizon and our automated liquid handling solutions can help you get there faster. From acoustic dispensing to tip-based liquid handling to fully integrated systems— we’re here to help you expand your scientific boundaries.
Here’s a look at a few of the solutions that will be in display on our booth at NextGen Omics US 2023:
Biomek NGeniuS Next Generation Library Prep System
- A purpose-built liquid handler for NGS library preparation, the Biomek NGeniuS Next Generation Library Prep System reduces manual transfers and hands-on time for the traditionally labor-intensive process of library construction.
Biomek i-Series Automated Workstations
- Representing the best of what has made Biomek workstations an industry leader—combined with enhancements suggested by customers around the globe—Biomek i-Series Automated Workstations have been designed to optimize dependability and walk-away time in mid- to high-throughput labs.
Echo 525 Acoustic Liquid Handler
- Echo acoustic liquid handlers use sound energy to precisely transfer liquid without contact, pipette tips, nozzles or tubing. Designed specifically for biochemical and genomic assays, the Echo 525 acoustic liquid handler delivers unparalleled accuracy and precision to improve assay reliability and data quality. It transfers aqueous samples and reagents rapidly in a stream of 25 nL droplets.
Apostle MiniMax™ High Efficiency Isolation Kit
- The Apostle MiniMax™ High Efficiency Isolation Kit enables you to extract more cfDNA than other isolation kits. It isolates cfDNA from 1-5 mL of plasma, is compatible with a variety of cell-free DNA collection tubes and efficiently removes PCR inhibitors to allow for use in NGS and PCR-based assays.
What’s Happening on Stage
Session Title
Detection of mutations in matched FFPE and cfDNA samples
Thursday, March 30
12:05 – 12:35 p.m.
About Han Wei
Han Wei, Ph.D., is a Market Development Scientist at Beckman Coulter Life Sciences, whose work is focused on building collaborative relationships with external partners. Prior to joining Beckman Coulter Life Sciences, Han worked as a Research Associate and Postdoctoral Fellow at Indiana University School of Medicine. She received her Doctor of Philosophy in Biochemistry & Molecular Biology at the Graduate University of Chinese Academy of Sciences, Beijing, China, and a Master of Medicine in Toxicology at The Academy of Military Medical Sciences, Beijing, China. She also received a Bachelor of Medicine in Clinical Medicine (B.M.E.D., – equivalent to M.D.) at Southern Medical University in Guangdong, China.
These products are not intended or validated for use in the diagnosis of disease or other conditions.
©2023 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the Stylized Logo, and Beckman Coulter product and service marks mentioned herein, including Biomek and Biomek NGeniuS, are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. ECHO is a trademark or registered trademark of Labcyte Inc. in the United States and other countries. Labcyte is a Beckman Coulter company. All other trademarks are the property of their respective owners.
